Measles-containing-vaccine first-dose (MCV1) immunization coverage in Cyprus
Cyprus: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 91.0% in 2025. ▬ Flat
Latest (2025)
91.0%
Change on year
down 8.1%
World rank
91st
of 194 countries
All-time high
99.0%
in 2024
All-time low
82.0%
in 2023
Years of data
26
2000–2025
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Cyprus, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Cyprus recorded 91.0% for measles-containing-vaccine first-dose (mcv1) immunization coverage in 2025.
The figure is down 8.1% on the previous year and up 1.1% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Cyprus peaked at 99.0% in 2024 and was at its lowest, 82.0%, in 2023.
That places Cyprus 91st out of 194 countries with data for 2025, putting it in the middle of the range.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Cyprus, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 86.0% | — |
| 2001 | 86.0% | +0.0% |
| 2002 | 86.0% | +0.0% |
| 2003 | 86.0% | +0.0% |
| 2004 | 86.0% | +0.0% |
| 2005 | 86.0% | +0.0% |
| 2006 | 87.0% | +1.2% |
| 2007 | 87.0% | +0.0% |
| 2008 | 87.0% | +0.0% |
| 2009 | 87.0% | +0.0% |
| 2010 | 87.0% | +0.0% |
| 2011 | 87.0% | +0.0% |
| 2012 | 86.0% | -1.1% |
| 2013 | 86.0% | +0.0% |
| 2014 | 86.0% | +0.0% |
| 2015 | 90.0% | +4.7% |
| 2016 | 90.0% | +0.0% |
| 2017 | 90.0% | +0.0% |
| 2018 | 90.0% | +0.0% |
| 2019 | 86.0% | -4.4% |
| 2020 | 86.0% | +0.0% |
| 2021 | 86.0% | +0.0% |
| 2022 | 84.0% | -2.3% |
| 2023 | 82.0% | -2.4% |
| 2024 | 99.0% | +20.7% |
| 2025 | 91.0% | -8.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 86.4% | 86.0% | 87.0% | 10 |
| 2010s | 87.8% | 86.0% | 90.0% | 10 |
| 2020s | 88.0% | 82.0% | 99.0% | 6 |
Countries ranked near Cyprus
More health data for Cyprus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.51 % change on previous year (2090)
- Heat deaths vs projected death rates 1,325 (2090)
- Un projection of annual infant deaths 7 (2100)
- Population ages 65 and above, female, annual growth rate 2.96 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0803 units per person (2025)
- Population ages 65 and above, male, annual growth rate 3.27 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.069 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Cyprus?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Cyprus was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Cyprus?
- The highest recorded value was 99.0% in 2024.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Cyprus?
- The lowest recorded value was 82.0% in 2023.
- How does Cyprus rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Cyprus ranks 91st out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Cyprus?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is flat.
- Where does this Cyprus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).